×

Warning

Failed loading XML file.
StartTag: invalid element name
Extra content at the end of the document

FONT

MORE STORIES


SPONSORED CONTENT: The People of Providence is brought to you by the Providence Foundations of Oregon

R. Bryan Bell, M.D., D.D.S., FACSMeet R. Bryan Bell, M.D., D.D.S., FACS

Director, Providence Oral, Head and Neck Cancer Program and Clinic; Investigator, Robert W. Franz Cancer Research Center at Earle A. Chiles Research Institute, Providence Cancer Center

Education and training

• D.D.S., Creighton University

• M.D., University of North Carolina at Chapel Hill

• Surgical training, University of North Carolina at Chapel Hill

Why Providence?

Providence doctors are leaders in cancer immunotherapy, which is transforming the practice of oncology. I came to Providence to help build a head and neck cancer program with world-class clinicians and scientists.

What is your dream for Providence in Oregon?

As a cancer surgeon and researcher, my goal is to ultimately put myself out of a job. The work we're doing at Providence using the immune system to fight cancer will fundamentally change treatment and may render current therapies obsolete.

What are your hobbies?

I enjoy spending time with my family, fishing, golfing and traveling.

What's a great memory you've had at Providence?

One of my former patients, Becky, is a young mother and wife who underwent extensive treatment for advanced oral cancer, including using both fibula (leg) bones to reconstruct her jaw. She later ran the Boston Marathon in under four hours, and today she is seven years post-treatment and lives happily without cancer!

Who were your mentors?

My father, an oral and maxillofacial surgeon-scientist, was never satisfied with the status quo. He took problems he encountered in his clinical practice to the laboratory, studied them, and translated what he learned back to his patients for the best treatment.

Why does philanthropy matter to your work?

Government funding for cancer research is near an all-time low. That means we rely more than ever on philanthropy to discover new treatments, such as anti-OX40 - an immunotherapy currently in early-phase trials for patients with head and neck cancer - that was developed entirely at Providence.

Join us.

FINISHCANCER.ORG/oregon

PROVIDENCE Foundations of Oregon

Contract Publishing

Go to top
Template by JoomlaShine